A report prepared by Dr Rotblat for the CMO repeated Armour's claim that they had done viral inactivation studies "and shown good inactivation".
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Frances Rotblat